Concepedia

Author

Eva Calvo-Pinilla

Centro de Investigación en Sanidad AnimalORCID

Also Known As

Calvo-Pinilla, E., E Calvo-Pinilla, E. Calvo-Pinilla, Eva Calvo-Pinilla

51

Publications

1.1K

Citations

21

H-Index

20

Concepts

All Affiliations

Centro de Investigación en Sanidad AnimalThe Pirbright InstituteInstituto Nacional de Investigación y Tecnología Agraria y AlimentariaCentro Regional de Selección y Reproducción AnimalUniversidade de Santiago de Compostela
EC

About

Eva Calvo-Pinilla is an author at Centro de Investigación en Sanidad Animal specializing in medicine, virology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

306

2

Immunology

9

9

306

3

Allergy

1

1

31

4

Epidemiology

1

1

64

5

Microbiology

1

1

37

Eva Calvo-Pinilla

×

25

Publications

832

Citations

18

H-Index

YearCitations

Establishment of a Bluetongue Virus Infection Model in Mice that Are Deficient in the Alpha/Beta Interferon Receptor

Eva Calvo-Pinilla, Teresa Rodríguez-Calvo, Juan Anguíta,

PLoS ONE

2009

85

Heterologous prime boost vaccination with DNA and recombinant modified vaccinia virus Ankara protects IFNAR(−/−) mice against lethal bluetongue infection

Eva Calvo-Pinilla, Teresa Rodríguez-Calvo, Noemı́ Sevilla,

Vaccine

2009

73

A Modified Vaccinia Ankara Virus (MVA) Vaccine Expressing African Horse Sickness Virus (AHSV) VP2 Protects Against AHSV Challenge in an IFNAR −/− Mouse Model

Javier Castillo‐Olivares, Eva Calvo-Pinilla, Isabel Casanova,

PLoS ONE

2011

64

Multiserotype Protection Elicited by a Combinatorial Prime-Boost Vaccination Strategy against Bluetongue Virus

Eva Calvo-Pinilla, Nicolás Navasa, Juan Anguíta,

PLoS ONE

2012

57

Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge

Berta Alberca, Katarzyna Bachanek‐Bankowska, Marta Cabana,

Vaccine

2014

52

Protection of IFNAR (−/−) Mice against Bluetongue Virus Serotype 8, by Heterologous (DNA/rMVA) and Homologous (rMVA/rMVA) Vaccination, Expressing Outer-Capsid Protein VP2

Tamara Jabbar, Eva Calvo-Pinilla, Francisco Mateos,

PLoS ONE

2013

50

Immunization of knock-out α/β interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen

Valentina Franceschi, Antonio Capocefalo, Eva Calvo-Pinilla,

Vaccine

2011

50

VP2, VP7, and NS1 proteins of bluetongue virus targeted in avian reovirus muNS-Mi microspheres elicit a protective immune response in IFNAR(−/−) mice

Alejandro Marín-López, Iria Otero-Romero, F. Poza,

Antiviral Research

2014

37

A protective bivalent vaccine against Rift Valley fever and bluetongue

Eva Calvo-Pinilla, Alejandro Marín-López, Sandra Moreno,

npj Vaccines

2020

35

Ns1 Is a Key Protein in the Vaccine Composition to Protect Ifnar(−/−) Mice against Infection with Multiple Serotypes of African Horse Sickness Virus

F. Poza, Eva Calvo-Pinilla, Elena López-Gil,

PLoS ONE

2013

32

Page 1